John A. Ward

Array ( [id] => 4409550 [patent_doc_number] => 06232523 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-15 [patent_title] => 'Metastasis models using green fluorescent protein (GFP) as a marker' [patent_app_type] => 1 [patent_app_number] => 8/848539 [patent_app_country] => US [patent_app_date] => 1997-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3554 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 106 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/232/06232523.pdf [firstpage_image] =>[orig_patent_app_number] => 848539 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4284898 [patent_doc_number] => 06235280 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-22 [patent_title] => 'Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1' [patent_app_type] => 1 [patent_app_number] => 8/838692 [patent_app_country] => US [patent_app_date] => 1997-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 14743 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/235/06235280.pdf [firstpage_image] =>[orig_patent_app_number] => 838692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1245888 [patent_doc_number] => 06677312 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-01-13 [patent_title] => 'Methods for restoring wild-type p53 gene function' [patent_app_type] => B1 [patent_app_number] => 08/825746 [patent_app_country] => US [patent_app_date] => 1997-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 13 [patent_no_of_words] => 12087 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 91 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/677/06677312.pdf [firstpage_image] =>[orig_patent_app_number] => 08825746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133445 [patent_doc_number] => 06121247 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Therapy for allergic diseases' [patent_app_type] => 1 [patent_app_number] => 8/826050 [patent_app_country] => US [patent_app_date] => 1997-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 4592 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121247.pdf [firstpage_image] =>[orig_patent_app_number] => 826050 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924395 [patent_doc_number] => 05952221 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-09-14 [patent_title] => 'Adeno-associated virus vectors comprising a first and second nucleic acid sequence' [patent_app_type] => 1 [patent_app_number] => 8/812102 [patent_app_country] => US [patent_app_date] => 1997-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 10 [patent_no_of_words] => 20435 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/952/05952221.pdf [firstpage_image] =>[orig_patent_app_number] => 812102 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4187077 [patent_doc_number] => 06093700 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-25 [patent_title] => 'Method of inducing an immune response using vaccinia virus recombinants encoding GM-CSF' [patent_app_type] => 1 [patent_app_number] => 8/732505 [patent_app_country] => US [patent_app_date] => 1997-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5005 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/093/06093700.pdf [firstpage_image] =>[orig_patent_app_number] => 732505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4242318 [patent_doc_number] => 06080910 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-06-27 [patent_title] => 'Transgenic knockout animals lacking IgG3' [patent_app_type] => 1 [patent_app_number] => 8/803120 [patent_app_country] => US [patent_app_date] => 1997-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 20 [patent_no_of_words] => 18084 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/080/06080910.pdf [firstpage_image] =>[orig_patent_app_number] => 803120 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4201026 [patent_doc_number] => 06013780 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-11 [patent_title] => 'VEGF.sub.145 expression vectors' [patent_app_type] => 1 [patent_app_number] => 8/784551 [patent_app_country] => US [patent_app_date] => 1997-01-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 19047 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/013/06013780.pdf [firstpage_image] =>[orig_patent_app_number] => 784551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4234147 [patent_doc_number] => 06165779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-26 [patent_title] => 'Compositions and methods for therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/779627 [patent_app_country] => US [patent_app_date] => 1997-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 6588 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/165/06165779.pdf [firstpage_image] =>[orig_patent_app_number] => 779627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407459 [patent_doc_number] => 06300129 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Transgenic non-human animals for producing heterologous antibodies' [patent_app_type] => 1 [patent_app_number] => 8/758417 [patent_app_country] => US [patent_app_date] => 1996-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 103 [patent_figures_cnt] => 110 [patent_no_of_words] => 120643 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300129.pdf [firstpage_image] =>[orig_patent_app_number] => 758417 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4379600 [patent_doc_number] => 06303568 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-16 [patent_title] => 'Therapeutic antimicrobial polypeptides, their use and methods for preparation' [patent_app_type] => 1 [patent_app_number] => 8/749066 [patent_app_country] => US [patent_app_date] => 1996-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9633 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/303/06303568.pdf [firstpage_image] =>[orig_patent_app_number] => 749066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4141173 [patent_doc_number] => 06063375 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-16 [patent_title] => 'Semiallogeneic cell hybrids and related methods for treating cancer' [patent_app_type] => 1 [patent_app_number] => 8/707920 [patent_app_country] => US [patent_app_date] => 1996-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 2 [patent_no_of_words] => 5601 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/063/06063375.pdf [firstpage_image] =>[orig_patent_app_number] => 707920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4361516 [patent_doc_number] => 06274136 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-14 [patent_title] => 'Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease' [patent_app_type] => 1 [patent_app_number] => 8/654737 [patent_app_country] => US [patent_app_date] => 1996-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 18 [patent_no_of_words] => 8411 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/274/06274136.pdf [firstpage_image] =>[orig_patent_app_number] => 654737 [rel_patent_id] =>[rel_patent_doc_number] =>)